packageEncorafenib

encorafenib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Encorafenib is a BRAF protein kinase inhibitor used to treat melanoma and colorectal cancer, and has also been studied for lung cancer. It is authorised in the European Union for melanoma and colorectal cancers.

Summary written by glm-5.3-flash from Wikidata Q15409405 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:encorafenib
ATC codes:L01EC03
DrugBank:DB11718
PubChem CID:50922675
Wikidata:Q15409405
formula:C22H27ClFN7O4S
molar mass:540.011 g/mol (PubChem CID 50922675)
logP:2.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown